Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
ACADIA Pharmaceuticals Inc.
About ACAD
Acadia Pharmaceuticals Inc.is a biopharmaceutical company. The Company is focused on innovation that makes the difference for underserved neurological and rare disease communities around the world. Its commercial portfolio includes the first and only FDA-approved treatments for Parkinson's disease psychosis and Rett syndrome. It is also developing therapeutic advancements with diverse pipelines that include mid- to late-stage programs in Alzheimer's disease psychosis and Lewy body dementia psychosis, along with earlier-stage programs that address other underserved patient needs. Its pipeline of product candidates includes Remlifanserin (formerly ACP-204), ACP-211, ACP-711, ACP-271, ACP-259, and Antisense Oligonucleotide (ASO) Program. NUPLAZID is a selective serotonin inverse agonist/antagonist preferentially targeting the 5-HT2A receptor. NUPLAZID is developed for the treatment for Parkinson's Disease Psychosis. DAYBUE (trofinetide) is developed for the treatment of Rett Syndrome.
Market Capitalisation
$3.72B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
470
High today
$22.10
Low today
$21.57
Open price
$0.00
52-week high
$28.35
52-week low
$16.97
Ready to start your investing journey with Stake?
Open an accountHow do I buy ACAD shares in Australia?
Buying ACAD shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in ACADIA Pharmaceuticals Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in ACAD
What is the ticker symbol of ACADIA Pharmaceuticals Inc.?
The ticker symbol for ACADIA Pharmaceuticals Inc. is ACAD.
How much is one share of ACAD?
One share of ACAD is valued at $21.72 as of 13 May 2026.
What is the market capitalisation of ACADIA Pharmaceuticals Inc. ACAD?
As of 13 May 2026 ACADIA Pharmaceuticals Inc. has a market cap of $3.72B.
What is the P/E ratio of ACAD?
The Price to Earnings ratio of ACAD is 9.93.
What is the Earnings Per Share of ACAD?
The Earnings Per Share of ACAD is $2.19.
What is the 52-week high for ACADIA Pharmaceuticals Inc. stock?
The ACADIA Pharmaceuticals Inc. 52-week high stock price is $28.35.
What is the 52-week low for ACADIA Pharmaceuticals Inc. stock?
The ACADIA Pharmaceuticals Inc. 52-week low stock price is $16.97.
Can I buy ACAD shares through Stake, an investing platform like Sharesies and Hatch Invest?
Yes, the Stake investing platform allows you to buy ACAD shares and over 9,500 more stocks and ETFs on Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ACAD on Stake
- Buy ACAD from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of ACAD from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
ACAD related stocks